Evidence map›Paper›PMID 38463442›Full record

ArticleMachine learning in medical imaging. MLMI (Workshop)2024

Class-Balanced Deep Learning with Adaptive Vector Scaling Loss for Dementia Stage Detection.

Boning Tong, Zhuoping Zhou, Davoud Ataee Tarzanagh, Bojian Hou, Andrew J Saykin, Jason Moore, Marylyn Ritchie, Li Shen

Open access · greenAbstract read
In one paragraph

Article in Machine learning in medical imaging. MLMI (Workshop), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. SLR: A Modified Logistic Regression Model with Sinkhorn Divergence for Alzheimer's Disease Classification.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2025
    Article
  2. Ensuring Fairness in Detecting Mild Cognitive Impairment with MRI.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Boning TongUniversity of Pennsylvania, Philadelphia, PA 19104, USA.
Zhuoping ZhouUniversity of Pennsylvania, Philadelphia, PA 19104, USA.
Davoud Ataee TarzanaghUniversity of Pennsylvania, Philadelphia, PA 19104, USA.
Bojian HouUniversity of Pennsylvania, Philadelphia, PA 19104, USA.
Andrew J SaykinIndiana University, Indianapolis, IN 46202, USA.
Jason MooreCedars-Sinai Medical Center, Los Angels, CA 90069, USA.
Marylyn RitchieUniversity of Pennsylvania, Philadelphia, PA 19104, USA.
Li ShenUniversity of Pennsylvania, Philadelphia, PA 19104, USA.
University of Pennsylvania · USCedars-Sinai Medical Center · USIndiana University – Purdue University Indianapolis · US

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI Laurel A Beckett · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Technology Identification and Training CoreP30AG073105 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DEMIRIS, GEORGE, KARLAWISH, JASON H · 2021 to 2025
$21.2M
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease BiobanksU01AG068057 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christos Davatzikos, Heng Huang · 2020 to 2026
$20.7M
Artificial Intelligence Strategies for Alzheimer's Disease ResearchU01AG066833 · NIA · CEDARS-SINAI MEDICAL CENTER · PI MOORE, JASON H., RITCHIE, MARYLYN D · 2022 to 2025
$6.7M
Translational big data analytic approaches to advance drug repurposing for Alzheimer's diseaseR01AG071470 · NIA · UNIVERSITY OF PENNSYLVANIA · PI KIM, DOKYOON, NING, XIA · 2021 to 2025
$3.8M
Artificial Intelligence Strategies for Alzheimer's Disease ResearchR01AG066833 · NIA · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H., RITCHIE, MARYLYN D · 2021 to 2021
$1.6M
Informatics Algorithms for Genomic Analysis of Brain Imaging DataR01LM013463 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H., SAYKIN, ANDREW J · 2020 to 2023
$1.4M
NIA NIH HHS P30 AG073105NIA NIH HHS R01 AG066833NIA NIH HHS R01 AG071470NIA NIH HHS U01 AG024904NIA NIH HHS U01 AG066833NIA NIH HHS U01 AG068057NIA NIH HHS U19 AG024904NLM NIH HHS R01 LM013463
6 · The paper itself

Abstract

Alzheimer's disease (AD) leads to irreversible cognitive decline, with Mild Cognitive Impairment (MCI) as its prodromal stage. Early detection of AD and related dementia is crucial for timely treatment and slowing disease progression. However, classifying cognitive normal (CN), MCI, and AD subjects using machine learning models faces class imbalance, necessitating the use of balanced accuracy as a suitable metric. To enhance model performance and balanced accuracy, we introduce a novel method called VS-Opt-Net. This approach incorporates the recently developed vector-scaling (VS) loss into a machine learning pipeline named STREAMLINE. Moreover, it employs Bayesian optimization for hyperparameter learning of both the model and loss function. VS-Opt-Net not only amplifies the contribution of minority examples in proportion to the imbalance level but also addresses the challenge of generalization in training deep networks. In our empirical study, we use MRI-based brain regional measurements as features to conduct the CN vs MCI and AD vs MCI binary classifications. We compare the balanced accuracy of our model with other machine learning models and deep neural network loss functions that also employ class-balanced strategies. Our findings demonstrate that after hyperparameter optimization, the deep neural network using the VS loss function substantially improves balanced accuracy. It also surpasses other models in performance on the AD dataset. Moreover, our feature importance analysis highlights VS-Opt-Net's ability to elucidate biomarker differences across dementia stages.

Indexed as

Alzheimer’s DiseaseClass-Balanced Deep LearningHyperparameter OptimizationMild Cognitive ImpairmentNeuroimaging

Identifiers

PMID38463442
PMCPMC10924683
OpenAlexW4387640500

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.